CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic...
CONMED Q2 FY26 adjusted EPS rises 20% to $1.38; net sales increase 0.3% to $343.5 million
Conmed | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 343.49 M
CNMD: Q2 2026 delivered 6.0% organic sales growth and 20% higher adjusted EPS, with updated full-year guidance
CONMED Corporation to Participate in the Society of Robotic Surgery Annual Meeting
CONMED to attend Society of Robotic Surgery annual meeting
CONMED files Form 3 for EVP, CFO John Gallagher`